Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (7): 615-617.DOI: 10.3969/j.issn.1673-8640.2022.07.003

Previous Articles     Next Articles

Influence of specimen state on the accuracy of plasma Epstein-Barr virus DNA determination results

WANG Xiaoyu1, SEMIRE Ainiwaer2, LI Shijun1()   

  1. 1. Department of Clinical Laboratory,the First Affiliated Hospital of Dalian Medical University,Dalian 116011,Liaoning,China
    2. Department of Clinical Laboratory,Shache County People's Hospital Xinjiang Uygur Autonomous Region,Kashgar 844700,Xinjiang,China
  • Received:2021-07-14 Revised:2021-09-15 Online:2022-07-30 Published:2022-08-26
  • Contact: LI Shijun

Abstract:

Objective To investigate the expression of Epstein-Barr virus(EBV)DNA in hemolysis and lipoidemia of plasma samples. Methods A total of 40 plasma positive samples with confirmed EBV DNA were collected and divided into 2 groups randomly(20 cases for each group). The EBV DNA positive samples were mixed with sterilized distilled water in a 1∶1 ratio as control samples. The levels of EBV DNA in simulated hemolysis(hemoglobin concentration 60.50,30.25 and 15.13 g/L) and simulated lipoidemia(triglyceride concentration 6.36,4.24 and 2.12 mmol/L) were determined by fluorescence quantitative polymerase chain reaction(PCR),and statistical analysis was performed. Results When the hemoglobin concentrations were 60.50 and 30.25 g/L,the PCR results of EBV DNA positive plasma hemolysis samples and control samples showed statistical significance(P<0.05). When the hemoglobin concentration was 15.13 g/L,there was no statistical significance in the PCR results between EBV DNA positive plasma hemolysis samples and control samples(P>0.05). There was no statistical significance in the PCR results between lipoidemia samples and control samples(P>0.05). Conclusions Hemolysis samples with hemoglobin concentration ≤15.13 g/L and lipoidemia samples with triglyceride concentration ≤6.36 mmol/L had no effect on the determination of EBV DNA plasma samples.

Key words: Epstein-Barr virus DNA, Fluorescence quantitative polymerase chain reaction, Hemolysis, Lipoidemia

CLC Number: